Stock Region Penny Picks
Your daily dose of market insights, opinions, and opportunities.
Stock Region Penny Picks Watchlist Newsletter
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions. Stock Region is not responsible for any financial losses incurred.
🚀 Big Movers and Shakers
$TH - Target Hospitality
Target Hospitality is flexing its muscles with its 2025 results, showcasing significant strides in strategic growth initiatives. With customer demand accelerating, the company seems to be riding a wave of momentum. Could this be a long-term growth story in the making? Keep an eye on how they sustain this trajectory in 2026.
$CYN - Cyngn
Cyngn is on fire! The company is projecting Q1 sales to surpass all of 2025. That’s a bold claim, but if they deliver, it could be a game-changer. This kind of momentum is rare—definitely worth watching.
$KALA - Kala Bio
Kala Bio is diving headfirst into the AI healthcare revolution with the launch of its first AI agent in just 14 days. With a $180 billion market opportunity in agentic AI healthcare, this could be a biotech revolution in the making. The excitement is palpable, but as with all biotech plays, tread carefully.
$SGN - SGN
SGN is making waves in the AI data center space by teaming up with Supermicro. This collaboration could position SGN as a key player in the AI hardware ecosystem. If you’re bullish on AI infrastructure, this might be one to watch.
$NXPL - NextPlat
NextPlat’s Global Telesat just snagged an $820,000 contract for satellite-enabled connectivity hardware and services from a U.K. government prime supplier. This is a solid win that could pave the way for more government contracts.
$SCNX - SCIENTURE
SCIENTURE is expanding access to REZENOPY™, the highest-dose FDA-approved naloxone nasal spray, through agreements with over 5,000 U.S. institutions. This is a critical product in the fight against opioid overdoses, and its broader availability could have a significant societal impact.
$QNRX - Quoin Pharmaceuticals
Quoin Pharmaceuticals just got Fast Track Designation from the FDA for QRX003, a treatment for Netherton Syndrome. This is a rare disease, and the designation could speed up the path to market. Biotech investors, take note.
$ASNS - Actelis Networks
Actelis Networks is making moves in cybersecurity, securing a Japanese governmental order for cyber-hardened networking solutions. With critical infrastructure at stake, this could be a lucrative niche for the company.
📈 Earnings Highlights
$TLYS - Tilly’s
Tilly’s crushed expectations with quarterly earnings of $0.10 per share, a 166.67% beat over the consensus estimate of $(0.15). Sales also came in strong at $155.131 million, beating estimates by 4.32%. This is a remarkable turnaround from last year’s losses. Could this be the start of a new chapter for Tilly’s?
$VRA - Vera Bradley
Vera Bradley announced its Q4 FY2026 results along with leadership changes. While the details are still unfolding, leadership shifts often signal strategic pivots. Keep an eye on how the market reacts.
🌟 Emerging Opportunities
$SLAI - SOLAI
SOLAI has received a preliminary non-binding going-private proposal. At $1.23 per share, this could be an interesting play for those looking at short-term opportunities.
$MNDR - Mobile-health Network Solutions
Mobile-health Network Solutions is improving its gross margin and cash position while reducing operating expenses. This is a solid foundation for future growth, especially in the competitive healthcare tech space.
$NXGL - NEXGEL
NEXGEL saw a volume spike as it announced terms for licensing and acquiring a portfolio of commercial-stage regenerative biomaterial products. This could be a transformative move for the company.
$ISPC - iSpecimen
iSpecimen is launching an AI agent to revolutionize biospecimen matching. This is a niche but critical area in healthcare, and the use of AI could give them a significant edge.
This week’s watchlist is packed with companies making bold moves, from AI revolutions to biotech breakthroughs and earnings surprises. While the opportunities are exciting, remember that every investment carries risks. Stay informed, stay cautious, and happy investing!
Disclaimer: This newsletter is not financial advice. Always consult with a financial advisor before making investment decisions. Stock Region is not liable for any investment outcomes.